US Stock MarketDetailed Quotes

DOX Amdocs

Watchlist
  • 88.300
  • +1.070+1.23%
Close Feb 14 16:00 ET
  • 88.300
  • 0.0000.00%
Post 17:03 ET
9.96BMarket Cap20.44P/E (TTM)

Amdocs Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2024
(FY)Sep 30, 2024
(Q4)Sep 30, 2024
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
Total revenue
-10.85%1.11B
2.40%5B
1.72%1.26B
1.14%1.25B
1.84%1.25B
5.02%1.25B
6.79%4.89B
6.52%1.24B
6.52%1.24B
6.81%1.22B
Operating revenue
-10.85%1.11B
1.69%2.9B
0.47%721.42M
2.91%740.77M
1.84%1.25B
77.93%1.25B
3.67%2.86B
0.49%718.06M
0.27%719.84M
84.41%1.22B
Cost of revenue
-16.05%682.26M
2.84%3.25B
2.65%824.89M
0.74%809.97M
0.82%802M
7.39%812.74M
6.84%3.16B
6.95%803.6M
7.46%804.01M
7.32%795.49M
Gross profit
-1.08%427.8M
1.61%1.76B
0.01%438.99M
1.88%440.09M
3.75%443.85M
0.84%432.46M
6.70%1.73B
5.74%438.96M
4.82%431.96M
5.89%427.82M
Operating expense
-10.46%222.18M
-0.70%995.7M
-4.17%243.11M
0.11%249.51M
3.84%254.96M
-2.41%248.12M
5.07%1B
4.20%253.67M
2.67%249.24M
2.15%245.54M
Selling and administrative expenses
-14.33%122.09M
0.37%572.85M
-1.19%138.71M
0.17%144.03M
2.99%147.61M
-0.50%142.5M
7.97%570.71M
8.48%140.38M
5.63%143.78M
6.18%143.33M
Research and development costs
-5.46%84.33M
-3.75%360.8M
-7.80%90.07M
-1.95%90.37M
2.11%91.15M
-6.81%89.21M
5.68%374.86M
1.53%97.69M
3.00%92.16M
2.54%89.27M
Depreciation amortization depletion
-3.97%15.76M
8.57%62.05M
-8.13%14.33M
13.60%15.11M
25.18%16.2M
7.16%16.41M
-19.58%57.16M
-12.54%15.6M
-22.54%13.3M
-29.36%12.94M
-Depreciation and amortization
-3.97%15.76M
8.57%62.05M
-8.13%14.33M
13.60%15.11M
25.18%16.2M
7.16%16.41M
-19.58%57.16M
-12.54%15.6M
-22.54%13.3M
-29.36%12.94M
Operating profit
11.55%205.62M
4.80%759.7M
5.72%195.89M
4.31%190.58M
3.63%188.89M
5.57%184.33M
9.04%724.89M
7.92%185.29M
7.91%182.71M
11.38%182.28M
Net non-operating interest income expense
34.45%-6.41M
-845.20%-17.44M
3.67%10.86M
-55.44%-6.87M
-296.53%-11.65M
-97.02%-9.78M
79.70%-1.85M
5.81%10.48M
43.40%-4.42M
65.91%-2.94M
Non-operating interest income
----
-17.86%17.45M
----
----
----
----
171.68%21.25M
----
----
----
Non-operating interest expense
-34.45%6.41M
51.09%34.89M
----
----
296.53%11.65M
97.02%9.78M
36.56%23.09M
----
----
-65.91%2.94M
Total other finance cost
----
----
----
55.44%6.87M
----
----
----
----
-43.40%4.42M
----
Other net income (expense)
-6.78M
-74.41%-151.19M
-66.23%-103.31M
-14.72M
-33.16M
-1,087.30%-86.69M
-259.22%-62.15M
Gain on sale of security
----
-9.58%-13.21M
----
----
----
----
27.89%-12.06M
----
----
----
Special income (charges)
---6.78M
-84.89%-131.09M
-79.47%-83.21M
---14.72M
---33.16M
--0
-809.01%-70.9M
---46.37M
--0
--0
-Less：Restructuring and merger&acquisition
--6.78M
84.89%131.09M
79.47%83.21M
--14.72M
--33.16M
--0
--70.9M
--46.37M
--0
--0
-Gain on sale of business
----
--0
----
----
----
----
--0
----
----
----
Other non- operating income (expenses)
----
-84.76%-6.89M
----
----
----
----
-541.48%-3.73M
----
----
----
Income before tax
10.24%192.43M
-7.12%591.07M
-22.59%103.44M
-5.21%169M
-19.66%144.08M
20.29%174.56M
-1.86%636.36M
-18.67%133.62M
10.40%178.29M
15.68%179.34M
Income tax
57.05%40.57M
1.45%94.75M
-47.46%16.26M
54.02%28M
-15.06%24.66M
69.53%25.83M
-5.57%93.4M
-12.44%30.95M
-44.98%18.18M
937.81%29.03M
Net income
2.10%151.85M
-8.59%496.32M
-15.09%87.18M
-11.94%141M
-20.55%119.43M
14.51%148.72M
-1.19%542.96M
-20.37%102.67M
24.64%160.12M
-5.17%150.31M
Net income continuous Operations
2.10%151.85M
-8.59%496.32M
-15.09%87.18M
-11.94%141M
-20.55%119.43M
14.51%148.72M
-1.19%542.96M
-20.37%102.67M
24.64%160.12M
-5.17%150.31M
Minority interest income
-5.02%719K
38.66%3.12M
12.21%735K
3.20%709K
30.74%923K
269.27%757K
2.25M
655K
687K
706K
Net income attributable to the parent company
2.14%151.13M
-8.79%493.2M
-15.26%86.44M
-12.00%140.29M
-20.79%118.5M
14.11%147.97M
-1.60%540.71M
-20.88%102.01M
24.10%159.43M
-5.61%149.6M
Preferred stock dividends
Other preferred stock dividends
1.84%9.34M
-7.32%1.68M
-3.32%2.71M
-12.24%2.26M
16.36%9.17M
-4.27%1.82M
45.43%2.8M
10.28%2.57M
Net income attributable to common stockholders
2.14%151.13M
-8.97%483.86M
-15.41%84.76M
-12.16%137.58M
-20.94%116.24M
15.91%147.97M
-1.86%531.54M
-21.13%100.19M
23.78%156.63M
-5.85%147.03M
Basic earnings per share
5.51%1.34
-5.53%4.27
-11.63%0.76
-8.27%1.22
-17.74%1.02
18.69%1.27
1.12%4.52
-18.87%0.86
26.67%1.33
-3.88%1.24
Diluted earnings per share
5.56%1.33
-5.35%4.25
-11.63%0.76
-8.33%1.21
-17.89%1.01
17.76%1.26
1.13%4.49
-18.10%0.86
26.92%1.32
-3.91%1.23
Dividend per share
10.11%0.479
10.12%1.872
10.11%0.479
10.11%0.479
10.11%0.479
10.13%0.435
10.03%1.7
10.13%0.435
10.13%0.435
10.13%0.435
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Dec 31, 2024(FY)Sep 30, 2024(Q4)Sep 30, 2024(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023
Total revenue -10.85%1.11B2.40%5B1.72%1.26B1.14%1.25B1.84%1.25B5.02%1.25B6.79%4.89B6.52%1.24B6.52%1.24B6.81%1.22B
Operating revenue -10.85%1.11B1.69%2.9B0.47%721.42M2.91%740.77M1.84%1.25B77.93%1.25B3.67%2.86B0.49%718.06M0.27%719.84M84.41%1.22B
Cost of revenue -16.05%682.26M2.84%3.25B2.65%824.89M0.74%809.97M0.82%802M7.39%812.74M6.84%3.16B6.95%803.6M7.46%804.01M7.32%795.49M
Gross profit -1.08%427.8M1.61%1.76B0.01%438.99M1.88%440.09M3.75%443.85M0.84%432.46M6.70%1.73B5.74%438.96M4.82%431.96M5.89%427.82M
Operating expense -10.46%222.18M-0.70%995.7M-4.17%243.11M0.11%249.51M3.84%254.96M-2.41%248.12M5.07%1B4.20%253.67M2.67%249.24M2.15%245.54M
Selling and administrative expenses -14.33%122.09M0.37%572.85M-1.19%138.71M0.17%144.03M2.99%147.61M-0.50%142.5M7.97%570.71M8.48%140.38M5.63%143.78M6.18%143.33M
Research and development costs -5.46%84.33M-3.75%360.8M-7.80%90.07M-1.95%90.37M2.11%91.15M-6.81%89.21M5.68%374.86M1.53%97.69M3.00%92.16M2.54%89.27M
Depreciation amortization depletion -3.97%15.76M8.57%62.05M-8.13%14.33M13.60%15.11M25.18%16.2M7.16%16.41M-19.58%57.16M-12.54%15.6M-22.54%13.3M-29.36%12.94M
-Depreciation and amortization -3.97%15.76M8.57%62.05M-8.13%14.33M13.60%15.11M25.18%16.2M7.16%16.41M-19.58%57.16M-12.54%15.6M-22.54%13.3M-29.36%12.94M
Operating profit 11.55%205.62M4.80%759.7M5.72%195.89M4.31%190.58M3.63%188.89M5.57%184.33M9.04%724.89M7.92%185.29M7.91%182.71M11.38%182.28M
Net non-operating interest income expense 34.45%-6.41M-845.20%-17.44M3.67%10.86M-55.44%-6.87M-296.53%-11.65M-97.02%-9.78M79.70%-1.85M5.81%10.48M43.40%-4.42M65.91%-2.94M
Non-operating interest income -----17.86%17.45M----------------171.68%21.25M------------
Non-operating interest expense -34.45%6.41M51.09%34.89M--------296.53%11.65M97.02%9.78M36.56%23.09M---------65.91%2.94M
Total other finance cost ------------55.44%6.87M-----------------43.40%4.42M----
Other net income (expense) -6.78M-74.41%-151.19M-66.23%-103.31M-14.72M-33.16M-1,087.30%-86.69M-259.22%-62.15M
Gain on sale of security -----9.58%-13.21M----------------27.89%-12.06M------------
Special income (charges) ---6.78M-84.89%-131.09M-79.47%-83.21M---14.72M---33.16M--0-809.01%-70.9M---46.37M--0--0
-Less：Restructuring and merger&acquisition --6.78M84.89%131.09M79.47%83.21M--14.72M--33.16M--0--70.9M--46.37M--0--0
-Gain on sale of business ------0------------------0------------
Other non- operating income (expenses) -----84.76%-6.89M-----------------541.48%-3.73M------------
Income before tax 10.24%192.43M-7.12%591.07M-22.59%103.44M-5.21%169M-19.66%144.08M20.29%174.56M-1.86%636.36M-18.67%133.62M10.40%178.29M15.68%179.34M
Income tax 57.05%40.57M1.45%94.75M-47.46%16.26M54.02%28M-15.06%24.66M69.53%25.83M-5.57%93.4M-12.44%30.95M-44.98%18.18M937.81%29.03M
Net income 2.10%151.85M-8.59%496.32M-15.09%87.18M-11.94%141M-20.55%119.43M14.51%148.72M-1.19%542.96M-20.37%102.67M24.64%160.12M-5.17%150.31M
Net income continuous Operations 2.10%151.85M-8.59%496.32M-15.09%87.18M-11.94%141M-20.55%119.43M14.51%148.72M-1.19%542.96M-20.37%102.67M24.64%160.12M-5.17%150.31M
Minority interest income -5.02%719K38.66%3.12M12.21%735K3.20%709K30.74%923K269.27%757K2.25M655K687K706K
Net income attributable to the parent company 2.14%151.13M-8.79%493.2M-15.26%86.44M-12.00%140.29M-20.79%118.5M14.11%147.97M-1.60%540.71M-20.88%102.01M24.10%159.43M-5.61%149.6M
Preferred stock dividends
Other preferred stock dividends 1.84%9.34M-7.32%1.68M-3.32%2.71M-12.24%2.26M16.36%9.17M-4.27%1.82M45.43%2.8M10.28%2.57M
Net income attributable to common stockholders 2.14%151.13M-8.97%483.86M-15.41%84.76M-12.16%137.58M-20.94%116.24M15.91%147.97M-1.86%531.54M-21.13%100.19M23.78%156.63M-5.85%147.03M
Basic earnings per share 5.51%1.34-5.53%4.27-11.63%0.76-8.27%1.22-17.74%1.0218.69%1.271.12%4.52-18.87%0.8626.67%1.33-3.88%1.24
Diluted earnings per share 5.56%1.33-5.35%4.25-11.63%0.76-8.33%1.21-17.89%1.0117.76%1.261.13%4.49-18.10%0.8626.92%1.32-3.91%1.23
Dividend per share 10.11%0.47910.12%1.87210.11%0.47910.11%0.47910.11%0.47910.13%0.43510.03%1.710.13%0.43510.13%0.43510.13%0.435
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Many institutions are bullish! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1 Show More
China's asset revaluation sparks debate: What are mooers buying?
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.